Amphastar Pharma (AMPH) Reports Q1 Loss of 1c/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LITE
4. ABBV
5. CL
6. LYB
7. TFII
8. SPY
9. AAPL
10. MRVL

Go back to Amphastar Pharma (AMPH) Reports Q1 Loss of 1c/Share

Amphastar Pharmaceuticals Reports Net Revenues of $56.9 Million for the First Quarter Ended March 31, 2015

May 13, 2015 6:00 AM EDT

RANCHO CUCAMONGA, Calif., May 13, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq: AMPH) ("Amphastar" or the "Company") today reported results for the first quarter ended March 31, 2015.

Net revenues of $56.9 million for the first quarter GAAP net loss of $0.7 million, or $0.01 per diluted share for the first quarter Adjusted non-GAAP net loss of $0.4 million, or $0.01 per diluted share for the first quarter   Three Months Ended March 31,   2015 2014   (in thousands, except per share data) Net... More

Amphastar Pharmaceuticals to Present at the Bank of America Merrill Lynch 2015 Health Care Conference

May 11, 2015 6:00 AM EDT

RANCHO CUCAMONGA, Calif., May 11, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq: AMPH) announced today that Jason Shandell, President will be presenting at the Bank of America Merrill Lynch 2015 Health Care Conference on Thursday, May 14, 2015 at 9:20 a.m. Pacific Time in Las Vegas, NV.

This presentation will be made available with a live webcast and may be accessed by visiting the Amphastar's Pharmaceuticals website at... More